Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Research to Prevent Prescription Drug Overdoses, FOA CE12-007, initial review.
In accordance with Section 10(a)(2) of the Federal AdvisoryCommittee Act (92), the Centers for DiseaseControl and Prevention (CDC) announces the aforementioned meeting:
Time and Date: 12:00 p.m.-4:00 p.m., June 14, 2012 (Closed).
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to 92.
Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Research to Prevent Prescription Drug Overdoses, FOA CE12-007, initial review.”
Contact Person for More Information: Jane Suen, Dr.P.H., M.S., Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F63, Atlanta, Georgia 30341-3724, Telephone (770) 488-4281.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Dated: May 3, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office,Centers for Disease Control and Prevention.
[FR Doc. 2012-11551 Filed 5-11-12; 8:45 am]
BILLING CODE 4163-18-P